Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach

Curr Neuropharmacol. 2023;21(1):10-12. doi: 10.2174/1570159X20666220425133824.

Rafael G Dos Santos^{1

2}, Giordano Novak Rossi¹, Jaime E C Hallak^{1

2

3}, Dost Öngür⁴, Serdar M Dursun^{2

3}

¹ Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil.
² National Institute for Translational Medicine (INCT-TM), CNPq, Brazil.
³ Department of Psychiatry (Neurochemical Research Unit) and Neuroscience & Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
⁴ Psychotic Disorders Division, McLean Hospital/Department of Psychiatry, Harvard Medical School, Belmont, Mass., United States.

No abstract available

Publication types